Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDF
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 7-isopropoxyisoflavone
2. Fl-113
3. Osteoquine
4. Quinogin
5. Yambolap
1. 35212-22-7
2. Osten
3. 7-isopropoxyisoflavone
4. Osteofix
5. Yambolap
6. Iprosten
7. Ipriflavonum
8. Ipriflavona
9. Osteoquine
10. Ostivone
11. 7-isopropoxy-3-phenyl-4h-1-benzopyran-4-one
12. 3-phenyl-7-propan-2-yloxychromen-4-one
13. 7-isopropoxy-3-phenyl-4h-chromen-4-one
14. Ipriflavone [inn:jan]
15. Osten (tn)
16. Ipriflavone (osteofix)
17. Osteochin
18. Tc 80
19. 7-(1-methylethoxy)-3-phenyl-4h-1-benzopyran-4-one
20. Fl 113
21. Fl-113
22. Mls000069470
23. 3-phenyl-7-(propan-2-yloxy)-4h-chromen-4-one
24. Smr000059060
25. 4h-1-benzopyran-4-one, 7-(1-methylethoxy)-3-phenyl-
26. 80bj7wn25z
27. Chebi:31719
28. Nsc-755888
29. Ncgc00024094-04
30. Quinogin
31. Dsstox_cid_20679
32. Dsstox_rid_79537
33. Dsstox_gsid_40679
34. Iprivone
35. Ipriflavonum [inn-latin]
36. Ipriflavona [inn-spanish]
37. Cas-35212-22-7
38. Ccris 1920
39. Brn 4754346
40. Unii-80bj7wn25z
41. Ipriflavon
42. (ipriflavone)
43. Ipriflavone, Inn
44. 7-isoproxyisoflavone
45. Mfcd00221719
46. 7-isopropoxy-isoflavone
47. 7-isopropyloxy-isoflavone
48. Ipriflavone (jan/inn)
49. Ipriflavone [mi]
50. Opera_id_1176
51. Ipriflavone [inn]
52. Ipriflavone [jan]
53. Ipriflavone (jp17/inn)
54. Ipriflavone [vandf]
55. Cambridge Id 6663564
56. Cid_3747
57. Ipriflavone [mart.]
58. Oprea1_106310
59. Oprea1_275552
60. Ipriflavone [who-dd]
61. Mls000759494
62. Mls001146879
63. Mls001424060
64. Mls006011644
65. Schembl111472
66. 7-isopropoxy-3-phenyl-chromone
67. Chembl165790
68. Zinc4016
69. Ipriflavone, Analytical Standard
70. Dtxsid5040679
71. Bdbm43662
72. Sfbodokjtyaucm-uhfffaoysa-
73. Fl113
74. Hms2051j15
75. Hms2234m05
76. Hms3371e17
77. Hms3393j15
78. Hms3656k19
79. Hms3715d04
80. Tc-80
81. Tn-39
82. Amy25650
83. Hy-n0094
84. Tox21_111532
85. Tox21_113172
86. S2422
87. Stl512460
88. Akos003627375
89. Tox21_111532_1
90. Tox21_113172_1
91. Ac-8130
92. Ccg-100963
93. Cs-6395
94. Db13618
95. Nc00213
96. Nsc 755888
97. Ncgc00018139-01
98. Ncgc00018139-02
99. Ncgc00018139-03
100. Ncgc00018139-04
101. Ncgc00018139-05
102. Ncgc00018139-07
103. Ncgc00018139-08
104. As-12306
105. 3-phenyl-7-propan-2-yloxy-chromen-4-one
106. Db-048754
107. Ft-0621442
108. I0669
109. Sw197593-2
110. 3-phenyl-7-propan-2-yloxy-1-benzopyran-4-one
111. D01338
112. D70301
113. Ab00384280-21
114. 212i227
115. A822650
116. Sr-01000000042
117. 7-isopropoxy-3-phenyl-4h-1-benzopyran-4-one 97%
118. Q1097778
119. Sr-01000000042-2
120. 7-isopropoxy-3-phenyl-4h-1-benzopyran-4-one, 97%
121. F0196-0909
Molecular Weight | 280.3 g/mol |
---|---|
Molecular Formula | C18H16O3 |
XLogP3 | 4 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 3 |
Rotatable Bond Count | 3 |
Exact Mass | 280.109944368 g/mol |
Monoisotopic Mass | 280.109944368 g/mol |
Topological Polar Surface Area | 35.5 Ų |
Heavy Atom Count | 21 |
Formal Charge | 0 |
Complexity | 407 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
M - Musculo-skeletal system
M05 - Drugs for treatment of bone diseases
M05B - Drugs affecting bone structure and mineralization
M05BX - Other drugs affecting bone structure and mineralization
M05BX01 - Ipriflavone
Ipriflavone has known human metabolites that include 3-Phenyl-7-(1-methyl-2-hydroxyethoxy)-4H-1-benzopyran-4-one, 4H-1-Benzopyran-4-one, 3-(4-hydroxyphenyl)-7-(1-methylethoxy)-, and 7-Hydroxyisoflavone.
S73 | METXBIODB | Metabolite Reaction Database from BioTransformer | DOI:10.5281/zenodo.4056560
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Ipriflavone manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ipriflavone, including repackagers and relabelers. The FDA regulates Ipriflavone manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ipriflavone API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Ipriflavone manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Ipriflavone supplier is an individual or a company that provides Ipriflavone active pharmaceutical ingredient (API) or Ipriflavone finished formulations upon request. The Ipriflavone suppliers may include Ipriflavone API manufacturers, exporters, distributors and traders.
click here to find a list of Ipriflavone suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Ipriflavone Drug Master File in Japan (Ipriflavone JDMF) empowers Ipriflavone API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Ipriflavone JDMF during the approval evaluation for pharmaceutical products. At the time of Ipriflavone JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Ipriflavone suppliers with JDMF on PharmaCompass.
Ipriflavone Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Ipriflavone GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Ipriflavone GMP manufacturer or Ipriflavone GMP API supplier for your needs.
A Ipriflavone CoA (Certificate of Analysis) is a formal document that attests to Ipriflavone's compliance with Ipriflavone specifications and serves as a tool for batch-level quality control.
Ipriflavone CoA mostly includes findings from lab analyses of a specific batch. For each Ipriflavone CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Ipriflavone may be tested according to a variety of international standards, such as European Pharmacopoeia (Ipriflavone EP), Ipriflavone JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Ipriflavone USP).
LOOKING FOR A SUPPLIER?